Infectious Disease Puscast #38

October 5, 2023

On episode #38 of the Infectious Disease Puscast, Daniel reviews the infectious disease literature for the weeks of 9/14 – 9/27/23.

Host: Daniel Griffin and Sara Dong

Click arrow to play
Download Puscast 038 (20 MB .mp3, 28 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of Puscast!

  • Features of Long COVID identified through immune profiling (Nature)
  • Severity of influenza-associated hospitalizations by influenza type (The Lancet)
  • Cefazolin for the treatment of CNS infections (CID)
  • Rifampin based therapy for patients with Staphylococcus aureus native vertebral Osteomyelitis (CID)
  • State of the management of infections caused by multidrug-resistant organisms (CID)
  • Are contact precautions “essential” for the prevention of healthcare-associated methicillin-resistant Staphylococcus aureus? (CID)
  • Impact of the sequential implementation of a pharmacy-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal-swab ordering policy and vancomycin 72-hour restriction protocol on standardized antibiotic administration ratio (ICHE)
  • Update on outbreak of fungal meningitis among US residents who received epidural anesthesia at two clinics in Mexico (CID)
  • Paratracheal abscess by plant fungus Chondrostereum purpureum (MMCR)
  • Canadian Blood Services traceback investigation of a suspected case of transfusion-transmitted malaria (Transfusion)
  • Strongyloides infection screening in transplant candidates (TID)
  • The world of microbial odors (JID)

Music is by Ronald Jenkees

Leave a Reply

Your email address will not be published. Required fields are marked *

Content on this site is licensed by MicrobeTV, Inc. under a Creative Commons Attribution 3.0 License.